| Announce Date | 11/10/2025 |
| EPS Normalized Actual | $0.16 In Line |
| EPS GAAP Actual | $0.16 In Line |
| Revenue Actual | $23.0525B |
| Revenue Surprise | Beat by $23052.5M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.66414 |
| EPS GAAP Estimate | $1.66414 |
| Revenue Estimate | $16.11736834B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 11.34717 | 1.51 | 10.44443 | 12.59608 | 2 |
| Dec 2026 | 51.68575 | 0.33 | 30.86073 | 70.56329 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.69 | -1.7724 | 23.0525B | 2.03% | 18659.49M |
| FQ2 2025 (Jun 2025) | 1.17 | -1.0395 | 26.0106B | 10.15% | 21617.59M |
| FQ1 2025 (Mar 2025) | 2.25 | 0.88769 | 23.3283B | 51.87% | 21131.8M |
| FQ4 2024 (Dec 2024) | 0.48 | -1.88494 | 31.1251B | 35.09% | 27801.39M |
| FQ3 2024 (Sep 2024) | 0 | -1.54141 | 22.5846B | 21.14% | -21254.22M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 23.3704B | 16.63% | 23370.4M |
| FQ1 2024 (Mar 2024) | 0.39 | 0.39 | 11.2273B | -80.61% | 11227.3M |
| FQ4 2023 (Dec 2023) | 0.57 | 0.57 | 20.2042B | 17.11% | 20204.2M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.66414
Consensus Revenue Estimates
16.11736834B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.2634 | -- | 1.92257 | 2.74538 | 1 |
| FQ3 2027 (Sep 2027) | 3.04748 | -- | 1.95217 | 3.47677 | 1 |
| FQ2 2027 (Jun 2027) | 3.04748 | -- | 1.95217 | 3.47677 | 1 |
| FQ1 2027 (Mar 2027) | 1.53215 | -- | 1.30144 | 1.85841 | 1 |
| FQ4 2026 (Dec 2026) | 2.54767 | -- | 2.4905 | 2.58558 | 1 |
| FQ3 2026 (Sep 2026) | 3.4257 | 79.86 | 3.08677 | 4.77248 | 1 |
| FQ2 2026 (Jun 2026) | 3.4257 | 65.85 | 3.08677 | 4.77248 | 1 |
| FQ1 2026 (Mar 2026) | 1.66414 | -35.2 | 1.6268 | 1.6889 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 33.81B | -- | 29.9B | 39.35B | 2 |
| FQ3 2027 (Sep 2027) | 34.28B | -- | 24.8B | 38B | 1 |
| FQ2 2027 (Jun 2027) | 34.28B | -- | 24.8B | 38B | 1 |
| FQ1 2027 (Mar 2027) | 20.29B | -- | 17.94B | 23.61B | 2 |
| FQ4 2026 (Dec 2026) | 26.86B | -- | 26.4B | 27.17B | 2 |
| FQ3 2026 (Sep 2026) | 34.45B | 33.08 | 31.82B | 44.86B | 2 |
| FQ2 2026 (Jun 2026) | 34.45B | 24.49 | 31.82B | 44.86B | 2 |
| FQ1 2026 (Mar 2026) | 16.12B | -44.74 | 15.84B | 16.3B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.4624 | 0.69 | -1.7724 | -256.87% |
| FQ2 2025 (Jun 2025) | 2.2095 | 1.17 | -1.0395 | -88.85% |
| FQ1 2025 (Mar 2025) | 1.36231 | 2.25 | 0.88769 | 39.45% |
| FQ4 2024 (Dec 2024) | 2.36494 | 0.48 | -1.88494 | -392.7% |
| FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0.39 | 0.39 | 100% | |
| FQ4 2023 (Dec 2023) | 0.57 | 0.57 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $4.39B | $23.05B | $18659.49M | 80.94% |
| FQ2 2025 (Jun 2025) | $4.39B | $26.01B | $21617.59M | 83.11% |
| FQ1 2025 (Mar 2025) | $2.2B | $23.33B | $21131.8M | 90.58% |
| FQ4 2024 (Dec 2024) | $3.32B | $31.13B | $27801.39M | 89.32% |
| FQ3 2024 (Sep 2024) | $43.84B | $22.58B | $-21254.22M | -94.11% |
| FQ2 2024 (Jun 2024) | $0B | $23.37B | $23370.4M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $11.23B | $11227.3M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $20.2B | $20204.2M | 100% |